Dosing and Monitoring of Isoniazid in a Preterm, Extremely Low Birth Weight Infant After In Utero Exposure to Mycobacterium tuberculosis: A Case Study and Literature Review

Pediatr Infect Dis J. 2022 Dec 1;41(12):967-969. doi: 10.1097/INF.0000000000003718. Epub 2022 Sep 22.
No abstract available

Publication types

  • Review

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Humans
  • Infant
  • Infant, Extremely Low Birth Weight
  • Infant, Newborn
  • Isoniazid / therapeutic use
  • Mycobacterium tuberculosis*
  • Tuberculosis, Lymph Node*

Substances

  • Isoniazid
  • Antitubercular Agents